SCHEMBL3662361

SCHEMBL3662361

CCC#CCCCOc1cccc(NC)c1F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.35
SLC6A4 P31645 2/20 0.33
HRH1 P35367 1/20 0.33
PPARG P37231 1/20 0.32
PPARA Q07869 1/20 0.32
PTPN1 P18031 1/20 0.32
APP P05067 1/20 0.32
CHRM2 P08172 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
LMNA P02545 1/20 0.32
CHRM1 P11229 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
ACHE P22303 1/20 0.32
KCNH2 Q12809 1/20 0.32
HIF1A Q16665 1/20 0.32
HTR1B P28222 2/20 0.31
CYP1A2 P05177 2/20 0.31
CYP2C19 P33261 2/20 0.31
CYP2D6 P10635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3659801 0.96 L3MBTL1 (0.37) L3MBTL1SLC6A4HRH1PPARGPPARA
SCHEMBL3662391 0.93 APP (0.33) L3MBTL1SLC6A4HRH1PTPN1APP
SCHEMBL3664058 0.92 L3MBTL1 (0.35) L3MBTL1SLC6A4HRH1PPARGPPARA
SCHEMBL3658303 0.88 PPARG (0.36) L3MBTL1SLC6A4HRH1PPARGPPARA
SCHEMBL3664404 0.87 SMN1; SMN2 (0.34) L3MBTL1SLC6A4HRH1PTPN1APP
SCHEMBL3661720 0.84 PTPN1 (0.33) L3MBTL1PPARGPPARAPTPN1APP
SCHEMBL3656186 0.84 APP (0.34) L3MBTL1APPCYP1A2KMT2AALDH1A1
SCHEMBL3660239 0.83 L3MBTL1 (0.35) L3MBTL1SLC6A4HRH1PPARGPPARA
SCHEMBL3660251 0.83 EGFR (0.34) L3MBTL1SLC6A4HRH1PTPN1APP
SCHEMBL3661499 0.82 L3MBTL1 (0.34) L3MBTL1SLC6A4HRH1PTPN1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME SUMITOMO CHIEMCAL COMPANY LIMITED (JP) 2010-12-09 US disclosed
EP-2215062-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME Sumitomo Chemical Company, Limited (JP) 2010-08-11 EP disclosed
WO-2009069792-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME ATL3, NAT1, C5 L3MBTL1 40/4885SLC6A4 3430/4885HRH1 132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.